What you'll learn
- How estrogen affects insulin sensitivity across the cycle and into menopause
- Why testosterone matters for women's metabolic function, not just men's
- How the liver processes hormones, and why liver enzymes read differently in women
- Which markers to test for a complete picture of metabolic and hormonal health
How estrogen affects insulin sensitivity
Estrogen plays a protective role in metabolic function during reproductive years. Research shows it improves insulin sensitivity by promoting glucose uptake in skeletal muscle and suppressing hepatic glucose production, meaning the liver releasing glucose into the bloodstream when it isn't needed.
This is why insulin resistance tends to increase as estrogen declines through perimenopause and menopause. Women who previously had stable blood sugar often see HbA1c drift upward and fasting glucose become less predictable through that transition. The change isn't primarily dietary or activity-related. It reflects the loss of estrogen's direct effect on insulin receptor signaling.
Where the fat goes
Estrogen also influences fat distribution, and the shift matters metabolically.
Higher estrogen
Subcutaneous storage
Fat stored under the skin. Metabolically quieter, and the pattern that dominates during reproductive years.
Lower estrogen
Visceral accumulation
Fat stored around the organs. Metabolically active, and it produces inflammatory cytokines that worsen insulin resistance further.
Metabolic load
Progesterone has a more complex relationship with metabolic function than estrogen. In the luteal phase, roughly days 15 to 28, progesterone rises and can mildly reduce insulin sensitivity. Research in Diabetes Care has documented that glucose tolerance is slightly worse in the luteal phase than the follicular phase in women with normal cycles.
Progesterone also competes for the same receptors as cortisol. When progesterone runs low relative to cortisol, the cortisol signal is amplified, which increases gluconeogenesis, the liver making new glucose, and promotes fat storage.
Women with low progesterone, common in perimenopause or with chronic stress, often show elevated morning fasting glucose even when daytime patterns look normal. Testing fasting glucose alone, without the hormonal context, makes that look like a diet problem.
Not just a men's marker
Testosterone is present and metabolically important in women, at much lower concentrations than in men. Low testosterone in women is associated with increased fat mass, reduced lean muscle, lower energy expenditure and worsened insulin resistance.
PCOS runs the other way. Elevated androgens including testosterone are common, and that pattern is strongly associated with insulin resistance and elevated liver enzymes.
Testosterone testing is a useful addition to a metabolic panel, particularly with unexplained weight gain, fatigue, or blood sugar changes that don't track with lifestyle. It adds context that cholesterol and glucose alone cannot.
How hormones get cleared
The liver metabolizes and clears estrogen, progesterone and testosterone from circulation. When it's under stress, whether from fat accumulation, alcohol or metabolic dysfunction, that clearance becomes less efficient. The result can be estrogen dominance relative to progesterone even when estrogen itself reads normal on a test.
Women with elevated liver enzymes frequently also show disrupted estrogen metabolism, irregular cycles or worsening PMS. The connection runs both ways: hormonal imbalance increases liver load, and impaired liver function worsens hormonal imbalance.
Estrogen testing and what levels reveal
Estrogen testing in a metabolic context looks at estradiol, the most metabolically active form. Estradiol fluctuates through the cycle, so timing matters. The follicular phase baseline, days 3 to 5, is a standard reference point.
Through perimenopause and menopause, estradiol declines and becomes more variable before settling at lower postmenopausal levels. The metabolic impact of that transition is most measurable through the markers estrogen was protecting: insulin sensitivity, triglycerides, LDL cholesterol and visceral fat.
The markers worth reviewing together
Assessing metabolic health in women means looking across both systems at once. Separating hormones from metabolic markers hides the interactions that explain why results shift.
| Marker | What it reflects | Optimal |
|---|---|---|
| HbA1c | Average blood glucose over 2 to 3 months | <5.6% |
| Fasting glucose | Baseline glucose regulation | <100 mg/dL |
| Triglycerides | Sensitive to estrogen status, tend to rise in perimenopause | <150 mg/dL |
| ALT and AST | Liver cell stress, which reflects hormone processing efficiency | Women: ALT <45 U/L |
| GGT | Oxidative stress and liver load | Women: <9 U/L |
| CRP | Systemic inflammation, which estrogen decline tends to increase | <1 mg/L |
| Estradiol | Baseline reference, read against cycle phase | Varies by phase |
| Testosterone | Total and free, relevant for PCOS and lean mass | Varies by age |
| Cortisol | Morning levels, which affect fasting glucose patterns | 6 to 18 ug/dL |
When to test and how often
Timing changes what the number means
- Hormone markers
- A consistent cycle day reduces variability and makes trends interpretable. Days 3 to 5 for a follicular baseline, days 19 to 21 for luteal progesterone.
- Metabolic markers
- Cycle timing matters less for liver enzymes and glucose, but fasting status matters for glucose and triglycerides.
- How often
- For women in perimenopause or with known PCOS, every 3 to 6 months gives enough resolution to see whether an intervention is working before changes become entrenched.
Conclusion
Metabolic health in women is inseparable from hormonal health. Estrogen, progesterone and testosterone all directly affect insulin sensitivity, fat distribution and liver enzyme patterns. Testing these systems together rather than in isolation gives a more complete picture of what's actually driving the numbers you see.
The goal isn't a one-time snapshot. Tracking both over time, particularly through hormonal transitions, is where the useful information lives.
The hormone side
Women's Longevity Panel
Estradiol, progesterone and testosterone alongside thyroid and cholesterol markers.
- Hormones
- Estradiol, progesterone, total and free testosterone, SHBG
- Also covers
- TSH, cholesterol panel, hemoglobin, hematocrit, creatinine
$195
Explore the panel ↗The metabolic side
Comprehensive Liver Function Test
Liver enzymes with the glucose, insulin and lipid markers that shift through hormonal transitions.
- Metabolic
- Fasting glucose, fasting insulin, HbA1c, HOMA-IR
- Also covers
- ALT, AST, GGT, albumin, bilirubin, triglycerides, LDL, HDL, ApoB, iron
This article is for informational purposes and is not a substitute for medical advice, diagnosis or treatment. Hormone results depend on where you are in your cycle and should be interpreted by a healthcare provider alongside your symptoms and history. Reference ranges vary between laboratories. Do not start, stop or change hormone therapy or medication based on at-home test results.
.png)
